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Background & Aim: The amount of coronary calciﬁcation mea-
sured by coronary computed tomography (CCT) correlates with
increased risk of coronary events. We aimed to measure the effect
of coronary risk factors on the degree of coronary calciﬁcation in
clinically indicated CCT studies in the Saudi population.
Methods: Clinically indicated patients were scanned using 64
slice CCT to measure Agatston coronary calciﬁcation score.
Results: 1287 patients were scanned with mean age of
52 ± 13.2 years, 65% males, & 35% females. Chest pain was the
indication in 80% of cases. There was 37% diabetic, 58% hyperten-
sive, 23.6% hyperlipidemic, 13% smoker, and 32%with family his-
tory of coronary daises. The mean calcium score was high in males
compared to females, 99.6 ± 341, and 54.2 ± 182, P< 0.001, in
patients P40 years compared to <40 years, 92.5 ± 314, and
6.1 ± 39.4, P< 0.0001, in diabetic pat, compared to non-diabetic,
125.9 ± 387, and 52.7 ± 212, P< 0.0001, in hypertensive pat
compared to non-hypertensive, 114.8 ± 360, and 25 ± 107,
P< 0.0001, in hyperlipidemic pat compared to non-hyperlipi-
demic, 177.5 ± 407, and 44 ± 222, P< 0.0001, in n patients with
body mass index P25 compared to those <25, 72 ± 295, and
45 ± 141, P< 0.05 and in patients with HbA1c P8 compared to
<8, 152 ± 467, and 76.4 ± 365, P< 0.01.
Conclusion: Coronary calciﬁcation is signiﬁcantly higher in
patients with classical coronary risk factors. Poorly controlled
diabetes is associated with higher risk of coronary calciﬁcation.
doi:10.1016/j.jsha.2011.02.061
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Background: Femoral arterial sheath thrombosis and distal
embolization is a well-recognized complication of cardiac catheter-
ization and may result in serious comorbidities like acute leg ische-
mia. Heparinized saline ﬂushes are used during diagnostic
coronary angiography to prevent thrombus formation within the
lumen of the sheath. However, the use of prophylactic intravenous
heparin following the femoral arterial sheath insertion is contro-
versial. The aim of this study was to evaluate the effectiveness of
2000 units’ heparin intravenous bolus versus saline placebo on
thrombus formation within arterial sheath during the diagnostic
coronary angiography.
Methods: Eligible patients were randomized to receive either
study drug or placebo at the time of femoral sheath insertion.
Arterial access was obtained via femoral arterial approach using
access 6F–7F sheaths and catheters. The sheath was aspirated
and ﬂushed for presence of thrombus after each catheter exchange
and at the end of the procedure. Five milliliters of blood was ex-
tracted and visualized on clean gauze and if thrombus was noticed
further aspiration was performed followed by saline ﬂush. The
primary end point was the effectiveness of study drug on reducing
the incidence of sheath-thrombus formation.
Results: 304 patients were randomized into two arms: 147 pa-
tients received intravenous heparin and 157 patient received pla-
cebo. The baseline characteristics were similar. Sheath thrombi
were observed in 20% of the total cohort.
Of the heparin arm, 12% (19 patients) developed sheath
thrombus formation versus 26% (42 patients) in placebo arm, p
value = 0.002. Adjusted logistic regression showed that the only
predictor for the sheath thrombi formation was the study drug.
The odds ratio of developing a thrombus when a study drug is
not used was 2.5 (95% CI: 1.4–4.5, p= 0.003). There were no ad-
verse events noticed.
Conclusion: IV heparin signiﬁcantly reduced thrombus forma-
tion with no adverse events. Therefore, our data suggest using
IV heparin routinely.
doi:10.1016/j.jsha.2011.02.062
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Background: Contrast induced nephropathy CIN is an acute
deterioration of renal function deﬁned as increase in serum creat-
inine by 25% above the baseline value within 48 h after adminis-
tration of contrast agent, several risk factors may aggravate CIN
and DM is a strong predisposing factor.
Objectives: To study the effect of contrast administration on re-
nal function and the relation of diabetes mellitus and other risk
factors which can predispose patients to CIN.
Methods: Open label, single center study in cath lab a total of
1117 patients underwent cardiac catherization between January
and December 2009, all patients in that period included in this
study, Acute coronary syndrome and stable CAD patients.
Results: Total of 1117 patients, 55 (4%) patients developed
CIN, 35 (64%) patients are diabetics, 39 (71%) patients are hyper-
tensive, 38 (56%) patients under went diagnostic cardiac cath and
17 (34%) had PCI, 23 (41%) patients had body weight <70 kg
and 44 (80%) patients received omnipauqe contrast media.
Conclusion: This study conclude that hypertension and DM are
the major risk factors in our patients, diabetic patients in particu-
lar should be closely monitored for CIN and preventive measures
should be strictly enforced.
doi:10.1016/j.jsha.2011.02.063
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Introduction and aim of the study: Coronary Artery Disease
(CAD) in Saudis is reaching epidemic levels, Type II Diabetes
(DM) is the highest in the region. The pattern, and extent of Cor-
onary Athero-Thrombosis (CAT) is not studied. We aim to
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